Dietary flaxseed has significant anti-atherogenic effects. However, the limits of this action and its effects on vascular contractile function are not known. We evaluated the effects of flaxseed supplementation on atherosclerosis and vascular function under prolonged hypercholesterolemic conditions in New Zealand White rabbits assigned to one of 4 groups for 6, 8 or 16 weeks of feeding: regular diet (RG), 10% flaxseed supplemented diet (FX), 0.5% cholesterol supplemented diet (CH), and 0.5% cholesterol and 10% flaxseed supplemented diet (CF). Cholesterol feeding resulted in elevated plasma cholesterol levels and the development of atherosclerosis. The CF group had significantly less atherosclerotic lesions in the aorta and carotid arteries following 6 and 8 weeks than the CH animals. However, the anti-atherogenic effect of flaxseed Including flaxseed in the high cholesterol diet completely normalized the relaxation responses at 6 and 8 weeks and partially restored it at 16 weeks. No significant changes in the relaxation response induced by sodium nitroprusside were observed in any of the groups. In summary, dietary flaxseed is a valuable strategy to limit cholesterol-induced atherogenesis as well as abnormalities in endothelial-dependent vasorelaxation. However, these beneficial effects were attenuated during prolonged hypercholesterolemic conditions.
INTRODUCTION
8 mounted onto positive glass slides. Sections were stained with Oil Red O and counterstained with hematoxylin as previously described (44).
Following en face atherosclerosis analysis, the aortae were stored at -80 o C, thawed, and homogenized in preparation for chloroform:methanol lipid extraction as described in detail (4, 21). The extracted lipids were quantified as described above.
Experimental protocol for assessing vascular response
Aortic tissue, dissected into 3 mm width rings from the distal end of the aortic arch, were fastened in an organ bath with surgical wire, perfused with the Krebs
Henseleit solution, aerated with 95% O 2 and 5% CO 2 , and equilibrated at 37 o C and pH
Vascular function was measured with a force transducer as mechanograms of tension (tension (g)/tissue wet weight (g)).
The aortic rings were brought to a basal tension of 5.5-6.5 grams of tension and then contracted three times with 47 mM KCl with wash-out periods using Krebs solution between each contraction. Tissues were allowed to return to baseline tension during wash-outs. A dose response curve to norepinephrine (NE) was constructed with concentrations of 10 -9 M to 10 -4 M. After the final dose of NE, the tissues were washed-out with 37 o C Krebs Henseleit solution and allowed to return to baseline tension. To test the ability of the tissue to relax after pre-contraction with NE, a second dose of 10 -6 M NE was administered to the bath and the tissues were allowed to reach a steady state of contraction. Acetylcholine (ACh) was then administered without wash-out at concentrations of 10 -8 M to 10 -5 M to develop a relaxation response curve to ACh. Following wash-out and a third dose of 10 -6 M NE, sodium nitroprusside (SNP) was administered in selected experiments at concentrations of 10 -8 M to 10 -5 M to generate a relaxation response curve.
RESULTS

Diet composition and animal weights
Animals in all four treatment groups consumed 125g of chow daily. Animal body weights did not differ significantly amongst the four groups prior to feeding (0 weeks) or at the end of the feeding trials (6, 8, or 16 weeks) (data not shown), which suggests that the energy content of the experimental diets did not differ significantly. The data measuring the nutritional composition of the experimental diets supports this contention and is reported elsewhere (4). The addition of 10% flaxseed notably elevated the total fat and ALA content of the FX and CF diets. The n-6/n-3 PUFA ratios were 9-fold less in the flaxseed supplemented diets as compared to the RG and CH diets (4).
Effects on Lipid Concentrations
Initial plasma cholesterol and triglyceride levels were not significantly different amongst the four groups (Figure 1) . Following 6, 8 and 16 weeks of dietary treatment, animals fed a pro-atherogenic diet (CH and CF groups) had up to a 15-fold increase in plasma cholesterol levels as compared to the RG and FX groups (Figure 1a) . The cholesterol levels exhibited by these cholesterol-fed rabbits are similar to those found in hypercholesterolemic patients. There was no significant difference in plasma cholesterol levels between the CH and CF groups at any point in the trials. Plasma triglyceride levels were also elevated in the CH group at all time points (Figure 1b) . The addition of 10% flaxseed to the cholesterol diet significantly attenuated this rise. A general decrease in plasma triglyceride levels was noted in the cholesterol fed groups with an increasing length of feeding trial.
Plasma total fatty acid (TFA) levels were measured in all of the groups ( Table 1) .
The total fatty acid content was elevated in the plasma of the cholesterol fed groups following all end points. Notable differences in plasma fatty acid content are as follows:
palmitic acid (C16:0), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2 n-6), and arachadonic acid (C20:4 n-6) levels were all significantly higher in the CH and CF groups versus the RG and FX groups following 6, 8, and 16 weeks, with lower levels of the fatty acids in the CF group as compared to the CH group at 16 weeks. Alphalinolenic acid (C18:3 n-3) levels were elevated in animals fed both flaxseed and cholesterol following all feeding durations. A small rise was noted in plasma ALA levels of the cholesterol fed animals following 16 weeks. The long chain omega-3 fatty acid, eicosapentaenoic acid (EPA; C20:5 n-3) was only detected in the cholesterol fed groups following 16 weeks, with greater levels observed in the CF group. Docosahexaenoic acid (DHA; C22:6 n-3) levels in the plasma were only detected in trace amounts. The ratios of (n-6)/(n-3) PUFAs were significantly lower in the flaxseed supplemented groups (as much as 91-fold) as compared to the RG and CH groups with the difference diminishing with the length of feeding trial.
The dietary interventions also had an effect on the levels of lipid found in the vascular tissue following 8 and 16 weeks of treatment ( Table 2 ). The total fatty acid (TFA) content was elevated in the aortic tissue of the cholesterol fed groups, with the highest aortic TFA levels in the CF group. Notable differences in the aortic fatty acid content are as follows: levels of the longer chain fatty acids (C20:1, C20:2 n-6, C20:3 n-6, C22:1, and C24:1) were elevated in the cholesterol fed groups. Linoleic acid levels were elevated in the cholesterol fed groups at 8 and 16 weeks, and were highest in the CF group at 16 weeks. The long chain PUFA, arachadonic acid decreased significantly in the FX, CH and CF groups versus the RG group at 16 weeks. Aortic alpha-linolenic acid levels were elevated with flaxseed supplementation as well as in cholesterol fed animals at 8 weeks, however by 16 weeks, ALA levels were elevated only in the flaxseed fed groups, with the highest levels seen in the CF group. The long chain omega-3 fatty acid, eicosapentaenoic acid was detected only in the aortic tissue of the cholesterol fed groups at 8 weeks, and at 16 weeks was only observed in the CF group. Docosahexaenoic acid levels were also detected in the FX, CH, and CF groups following 8 weeks but only in the CF group following 16 weeks of feeding. At both time points, the highest values were detected in the CF group. The addition of dietary flaxseed diminished the (n-6)/(n-3)
PUFA ratio in the aortic tissues of the FX and CF groups as compared to the RG and CH groups.
Effects of dietary interventions on atherosclerosis
Tissue weights of the 3 mm aortic sections that were used to assess vascular response were not significantly different amongst the four groups following the 6 and 8 week trials. However, aortic tissue weights were significantly greater, due to large atherosclerotic lesions, in the CH and CF groups following the 16 week dietary intervention, as compared to the RG and FX groups (CH: 35.4 ± 2.3, CF: 39.0 ± 4.7, RG:
21.5 ± 0.8, and FX: 20.9 ± 1.5 mg).
Aortae were cut longitudinally and the luminal surface was digitally photographed to measure the atherosclerotic lesion area. Plaque formation was not visible in the aortae of the control and flax-fed animals at any timepoint. However, extensive atherosclerotic plaques were apparent in the cholesterol-fed rabbits (Figure 2 ). Both the cholesterol and cholesterol-flax fed groups had significantly greater plaque formation than the control and flax fed groups following all trials. There was a statistically significant inhibition of atherosclerotic plaque formation in the cholesterol-flax group in comparison to the animals fed cholesterol alone at the 6 and 8 week timepoints. In contrast, the CF group developed more atherosclerotic plaques than the CH group following 16 weeks of hypercholesterolemic conditions.
A similar qualitative effect on plaque formation was observed in cross sectional analysis ( Figure 3 ). Plaques were only present in cholesterol fed animals and were more severe in animals that did not receive flaxseed supplementation. However, at 16 weeks, the protective effects on plaque thickness were not observed.
Similar results with respect to atherosclerotic plaque formation were observed in carotid vessels although the extent of the atherosclerosis was not as severe ( Figure 4 ).
Carotids were not collected after the 6 week trial. After 8 weeks of dietary supplementation, atherosclerotic plaque formation in the carotids was inhibited by including flaxseed in the cholesterol diet. This protective effect was lost after 16 weeks of dietary intervention.
Effects of Dietary Flaxseed and Cholesterol on Vascular Contractile Response
The response of aortic rings from animals fed the different dietary regimens was Aortic relaxation responses were also monitored after pre-contraction with 10
NE as a function of the dietary interventions. Aortic rings from the CH group exhibited significantly less endothelium-dependent relaxation in response to higher doses of ACh Tables 1 & 2) . This elevation occurred in the absence or presence of additional dietary cholesterol. Although the plasma concentration of the longer chain omega-3 fatty acids EPA and DHA were only detected in low levels with cholesterol feeding following the extended feeding trials, EPA and DHA were detected in the aortic tissue of rabbits consuming both flaxseed and cholesterol following 8 weeks of feeding. The highest levels were seen in animals consuming a combination of cholesterol and flaxseed. These results demonstrate that ALA is metabolised to a small extent to longer chain fatty acids like EPA and DHA in the rabbit. Flaxseed supplementation also reduced the ratio of n-6 to n-3 PUFAs, primarily as a result of the elevated levels of circulating n-3 PUFA. The addition of dietary flaxseed to the atherogenic diet also mitigated the cholesterol-induced rise in plasma triglyceride levels (Figure 1b) . These results are consistent with previous work from our lab using this dietary intervention (4).
Our findings that dietary flaxseed can inhibit the development of atherosclerotic plaques on the aortic luminal surface are consistent with previous reports (41, 52, 54, 59, 64) . Because dietary flaxseed supplementation did not alter circulating cholesterol levels, either in the presence or in the absence of additional cholesterol in the diet (Figure 1a) , it is clear that its anti-atherogenic effects were not achieved through a cholesterol-lowering action. These effects are consistent with previous studies (2, 4, 24, 25, 52) , but in conflict with other reports which found that flaxseed supplementation lowers circulating cholesterol levels (41, 54, 56, 59) . Because the anti-atherosclerotic effects of fibre are due to a cholesterol-lowering action, the high fibre content of flaxseed, therefore, is unlikely to be responsible for the anti-atherogenic action in the present study. Alternatively, the lignan SDG in flaxseed has been shown to possess potent anti-atherogenic properties (52, 54, 57) and is the most likely component within the flaxseed responsible for these beneficial effects. It is a potent anti-oxidant (50, 51, 55). Our results extend these findings to demonstrate that the protection afforded by dietary flaxseed was also observed in an important resistance artery, the carotid (Figure 4) . Thus, the anti-atherogenic effects of flaxseed on atherosclerosis may have implications for the pathogenesis of stroke as well as heart disease. Consistent with this finding, several clinical studies have shown negative correlations between plasma ALA levels with the incidence of stroke (20, 37, 67) and coronary heart disease (17, 18, 27). However, our study has also identified limits to the anti-atherogenic capacity of flaxseed. The cholesterol and flax group also developed extensive atherosclerotic lesions after prolonged periods of hypercholesterolemia ( Figure   2 ). The extended duration of hypercholesterolemia appeared to overwhelm the beneficial effects of flaxseed supplementation.
The present study has demonstrated that dietary cholesterol had a deleterious effect on vascular contractile function (Figures 5 & 6) . These findings are consistent with the impaired vascular response of vessels exposed to a high cholesterol environment (9, (29) (30) (31) 69 ). The present results extend this to an attenuation of agonist-induced vascular contractility as well as an impairment of vascular relaxation. Because we observed defects in both KCl and NE-induced vascular tension generation, this suggests that there is a general defect in smooth muscle function. Cholesterol-induced changes in ion transport pathways including the regulation of Ca 2+ homeostasis in smooth muscle cells (SMC) may represent the mechanism for this effect (5, 6, 10, 13, 23, 65) . This may explain both the contraction and relaxation defects identified in the present study.
However, three additional factors may also play a role in the depressed contractile response to KCl and NE. First, tension generation was measured as a function of tissue weight. Tissue weight increased per length of each aortic ring in the cholesterol fed animals because the plaque increased the vessel thickness. This increase in tissue weight would tend to artificially decrease tension/tissue weight. Secondly, the plaque found in the aortic ring would contain non-muscular cell types such as fibroblasts, foam cells and macrophages that would contribute to tissue weight but not to total tension generation.
Thirdly, atherosclerosis is known to transform the phenotype of existing SMC from a contractile to a synthetic phenotype (1, 11, 46, 66, 73) (3, 16, 40, 45) . The protective effects on relaxation identified in our study clearly involved a selective, endothelium-dependent site of action. This finding is consistent with a study reporting that a high flaxseed diet can enhance endothelial vasorelaxant function in hypertensive rats, without improving blood pressure (71). The vascular response to SNP was not different in any of the groups demonstrating that the endothelial-independent routes of modulating vascular relaxation were unaltered ( Figure   8 ). Because there were no intrinsic changes in relaxation capacity in response to nitric oxide (NO) in the form of SNP, the lesion appears to be due to the generation of NO by
ACh. Because we did not observe any beneficial effects on vascular function of the flaxseed enriched diet on its own when compared to a regular diet, this would suggest that flaxseed is not altering the intrinsic characteristics of endothelial cells but instead selectively attenuates the detrimental changes induced by cholesterol. Flaxseed did not achieve this effect by altering the circulating cholesterol levels. In contrast, dietary flaxseed did increase PUFA levels in the plasma and aortic tissue. The largest changes in PUFA concentrations were in ALA levels in the tissue and plasma compartments with only minor changes in DHA and EPA levels. Therefore, it is reasonable to hypothesize that ALA induced the protective changes observed. In support of this contention, ALA has been shown to lower serum markers of vascular inflammation and endothelial activation (49, 60, 61, 72, 78) , reduce platelet aggregation (74) and induce changes in intracellular Ca 2+ movements (4, 15, 27) . Furthermore, circulating ALA has been positively associated with endothelium-dependent vasodilation in normocholesterolemic and hypercholesterolemic subjects (19, 63, 70) .
Oxidative stress may be another important mechanistic factor in cholesterolinduced vascular contractile dysfunction (22, 28, 33, 43) protective action in humans against vascular disease in both the heart and in stroke. Figure 8
